Long‐term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy‐induced eyelash hypotrichosis: a randomized controlled trial

BACKGROUND: Bimatoprost ophthalmic solution 0·03% is approved in several countries for the treatment of eyelash hypotrichosis. Previous trials were limited to 4 months of treatment and primarily idiopathic hypotrichosis. OBJECTIVES: To evaluate the long‐term safety and efficacy of bimatoprost in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaser, D.A., Hossain, P., Perkins, W., Griffiths, T., Ahluwalia, G., Weng, E., Beddingfield, F.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832276/
https://www.ncbi.nlm.nih.gov/pubmed/25296533
http://dx.doi.org/10.1111/bjd.13443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832276/
https://www.ncbi.nlm.nih.gov/pubmed/25296533
http://dx.doi.org/10.1111/bjd.13443

Ejemplares similares